Dexmethylphenidate
RxNorm 352372
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 352372 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: dexmethylphenidate.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
INPrescribable
Ingredient (IN):
Dexmethylphenidate
(Atom ID: 1551241)
PTPrescribable
Designated preferred name (PT):
Dexmethylphenidate
(Atom ID: 10297059)
FNPrescribable
Full form of descriptor (FN):
Dexmethylphenidate (substance)
(Atom ID: 10297060)
PTPrescribable
Designated preferred name (PT):
Dexmethylphenidate-containing product
(Atom ID: 10801030)
FNPrescribable
Full form of descriptor (FN):
Product containing dexmethylphenidate (medicinal product)
(Atom ID: 10305884)
Patient Education
Dexmethylphenidate
Dexmethylphenidate is used as part of a treatment program to control symptoms of attention deficit hyperactivity disorder (ADHD; more difficulty focusing, controlling actions, and remaining still or quiet than other people who are the same age) in adults and children. Dexmethylphenidate is in a class of medications called central nervous system (CNS) stimulants. It works by increasing the amounts of certain natural substances in the brain.
[Learn More]
* Please review the disclaimer below.